Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Bioanalytical Systems announced the most recent hiring related to the continued expansion of the Company’s pathology service offerings through ongoing investment and key hires.
read more
Pelican BioThermal has announced its latest partnership with Asiana Airlines.
read more
SCA Pharmaceuticals has entered into a definitive membership interest purchase agreement with The Vistria Group and Excellere Capital Management.
read more
To help sponsors and CROs get clinical trial sites up and running much faster, Cognizant’s SIP, a life sciences SaaS solution, is now integrated with Oracle Health Sciences.
read more
Piramal Pharma Limited's Pharma Solutions business announced it is providing Theratechnologies with GMP manufacturing of sterile fill/finish drug product.
read more
FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the COVID-19 pandemic.
read more
OpenEye Scientific and Sygnature Discovery announced the adoption of OpenEye's Orion platform to power Sygnature's computational efforts in molecular design drug discovery solutions.
read more
Repositive has announced IDMO will be joining its global network of CRO partners.
read more
Civica Rx has announced plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
read more
Thursday, January 21, 2021
Quanticate has named Lee Patterson as the company's Chief Operating Officer (COO).
read more
Thursday, January 21, 2021
Metrion Biosciences and LifeArc have announced a 12-month extension of their neuroscience drug discovery collaboration.
read more
Thursday, January 21, 2021
Oxford BioTherapeutics has selected a second bispecific program that will combine an anti-PD-L1 antibody with OBT’s immuno-oncology candidate.
read more
Thursday, January 21, 2021
Intravacc announced a candidate polyvalent inactivated coxsackievirus B vaccine it developed and manufactured for Provention Bio has entered into a first in human Phase I clinical study.
read more
Wednesday, January 20, 2021
Raremark has appointed Nicki Grundy as Chief Financial Officer to support the accelerated levels of growth the company is experiencing.
read more
Wednesday, January 20, 2021
Cobra Biologics, the gene therapy division of the Cognate BioServices’ group, has announced a multi-phase augmentation of its plasmid DNA services as a continuation of its Gene Therapy services’ expansion project for viral vectors and plasmid DNA.
read more